Rennert G
Department of Community Medicine, Kupat Holim Klalit, Carmel Hospital, Haifa, Israel.
Cancer Detect Prev. 1991;15(6):477-81.
Routine follow-up using screening mammography is currently considered the best method available for the early detection of breast cancer. The potential impact of such an activity is highly dependent on the size of the population suitable for and attending the screening program, and on the basic disease rates in this population. A computer-based model for designing cancer control strategies (CAN*TROL) was used. The screening scenario involved annual mammography of females 50 to 70 years of age in the two major Jewish ethnic groups in Israel. Two outcome parameters were studied: change in mortality rate and costs. Using the same scenario, a greater reduction in mortality rates was achieved in the whole screening period among European-American born females (-20%) than among Asian-African born females (-14.7%). Cost showed different trends over time in the two groups, but totaled about $130,000,000 in each of the screening groups. The total cost of saving one case of death from breast cancer was much less for European-Americans ($316,000) than for Asian-Africans ($1,944,000). These results reflect the higher risk for breast cancer among European-American females as well as the difference in age structure of these two groups. The planning of every screening program should include an effort to estimate the real impact on mortality and the cost-effectiveness in the specific population involved.
目前,使用乳腺钼靶筛查进行常规随访被认为是早期发现乳腺癌的最佳可用方法。此类活动的潜在影响在很大程度上取决于适合并参与筛查计划的人群规模,以及该人群中的基本疾病发病率。使用了一个基于计算机的癌症控制策略设计模型(CAN*TROL)。筛查方案包括对以色列两个主要犹太族群中50至70岁的女性进行年度乳腺钼靶检查。研究了两个结果参数:死亡率变化和成本。在相同方案下,在整个筛查期间,出生于欧美的女性的死亡率降幅更大(-20%),高于出生于亚非的女性(-14.7%)。两组的成本随时间呈现不同趋势,但每个筛查组的总成本约为1.3亿美元。对于欧美人来说,挽救一例乳腺癌死亡病例的总成本(31.6万美元)远低于亚非人群(194.4万美元)。这些结果反映了欧美女性患乳腺癌的风险更高,以及这两组人群年龄结构的差异。每个筛查计划的规划都应包括努力评估对死亡率的实际影响以及所涉及特定人群的成本效益。